Summary
Sorbitol dehydrogenase (SORD) was quantitatively assayed in a family in which four out of five brothers and their father had bilateral cataracts. Three sibs (two of them with cataracts) and both their father and paternal grandfather had SORD activity of about 25% of the reference values; of the other two affected sibs one had about 50% and the other had 75%; the mother and two paternal uncles had about 75%. These results do not define a clear cataract-SORD deficiency etiopathogenic relationship, nevertheless, they strongly suggest activity polymorphism in human red cell SORD, which would be highly relevant not only to the study of cataracts but of other major complications in diabetes.
Similar content being viewed by others
References
Asakura T, Adachi K, Minakami S, Yoshikawa H (1967) Nonglycolytic sugar metabolism in human erythrocytes. J Biochem (Tokyo) 62:184–193
Barretto OCO, Beutler E (1975) The sorbitol oxidizing enzyme of red blood cells. J Lab Clin Med 85:646–649
Beutler E, Mitchell M (1968) New rapid method for the estimation of red cell galactose-1-phosphate uridyltransferase activity. J Lab Clin Med 72:527–532
Beutler E, Matsumoto FT (1973) A rapid simplified assay for galactokinase activity in whole blood. J Lab Clin Med 82:818–821
Charlesworth D (1972) Starch-gel electrophoresis of four enzymes from human red blood cells: glyceraldehyde-3-phosphate dehydrogenase, fructoaldolase, glyoxalase II and sorbitol dehydrogenase. Ann Hum Genet 35:477–484
Corder CN, Braughler JM, Culp PA (1979) Quantitative histochemistry of the sorbitol pathway in glomeruli and small arteries of human diabetic kidney. Folia Histochem Cytochem (Krakow) 17:137–146
Crabbe MJC, Wolff S, Halder AB, Ting H-H (1981) Diabetic cataracts—is aldose reductase important? Metabol Ped Ophthalmol 5:33–38
Dvornik D, Simmard-Duquesne N, Krami M, Sestang K, Gabbay KH, Kinoshita JH, Varma SD, Merola LO (1973) Polyol accumulation in galactosemic and diabetic rats: Control by an aldose reductase inhibitor. Science 182:1146–1148
Gabbay KH (1973) The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831–836
Gabbay KH (1975) Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu Rev Med 26:521–536
Gabbay KH, Merola LO, Field RA (1966) Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151: 209–210
Ibarra B, González-Quiroga G, Vaca G, Díaz M, Rivas F, Cantú JM (1982) Sorbitol dehydrogenase (EC 1.1.1.14) polymorphism in human seminal plasma. Ann Génét (Paris) 25:53–55
Segal S (1978) Disorders of galactose metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, p 174
Shin-Buehring YS, Osang M, Ziegler R, Schaub J (1977) A simple assay for galactokinase using DEAE-cellulose column chromatography. Clin Chim Acta 74:1–5
Vaca G, Ibarra B, Bracamontes M, García-Cruz D, Sánchez-Corona J, Medina C, Wunsch C, González-Quiroga G, Cantú JM (1981a) Red blood cell sorbitol dehydrogenase (SDH) deficiency in a family with cataracts. Preliminary communication. 6th Int Cong Hum Genet, Jerusalem, Israel, Sept 13–18. (Book of abstract pag 92)
Vaca G, Sánchez-Corona J, García-Cruz D, Medina C, Wunsch C, González-Quiroga G, Ibarra B, Cantú JM (1981b) A screening test for sorbitol dehydrogenase (SDH) deficiency. Arch Biol Med Exp (Santiago) 14:87 (abstract)
van Heyningen R (1976) Sugar alcohols in the pathogenesis of galactose and diabetic cataracts. In: The eye and inborn errors of metabolism. Birth Defects XII:295–303
Varma SD, Mizuno A, Kinoshita JH (1977) Diabetic cataracts and flavonoids. Science 195:205–206
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaca, G., Ibarra, B., Bracamontes, M. et al. Red blood cell sorbitol dehydrogenase deficiency in a family with cataracts. Hum Genet 61, 338–341 (1982). https://doi.org/10.1007/BF00276598
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00276598